APA (7th ed.) Citation

Gauger, S. J., Lie, M. E. K., Wallaard, I., Tian, Y., Marek, A., Frølund, B., . . . Wellendorph, P. (2025). CaMKIIα hub ligands are unable to reverse known phenotypes in Angelman syndrome mice. Basic & Clinical Pharmacology & Toxicology, 136(1), 1. https://doi.org/10.1111/bcpt.14112

Chicago Style (17th ed.) Citation

Gauger, Stine J., et al. "CaMKIIα Hub Ligands Are Unable to Reverse Known Phenotypes in Angelman Syndrome Mice." Basic & Clinical Pharmacology & Toxicology 136, no. 1 (2025): 1. https://doi.org/10.1111/bcpt.14112.

MLA (9th ed.) Citation

Gauger, Stine J., et al. "CaMKIIα Hub Ligands Are Unable to Reverse Known Phenotypes in Angelman Syndrome Mice." Basic & Clinical Pharmacology & Toxicology, vol. 136, no. 1, 2025, p. 1, https://doi.org/10.1111/bcpt.14112.